Expect Equity LLC Has $1.29 Million Stock Holdings in Viemed Healthcare, Inc. $VMD

Expect Equity LLC boosted its holdings in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 59.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 173,970 shares of the company’s stock after buying an additional 64,961 shares during the period. Expect Equity LLC owned approximately 0.46% of Viemed Healthcare worth $1,293,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Lazard Asset Management LLC raised its holdings in Viemed Healthcare by 5.9% during the fourth quarter. Lazard Asset Management LLC now owns 99,238 shares of the company’s stock worth $737,000 after buying an additional 5,546 shares during the last quarter. Watershed Asset Management L.L.C. purchased a new stake in shares of Viemed Healthcare in the fourth quarter valued at about $466,000. Kemnay Advisory Services Inc. purchased a new stake in shares of Viemed Healthcare in the fourth quarter valued at about $46,000. Mangrove Partners IM LLC purchased a new stake in shares of Viemed Healthcare in the fourth quarter valued at about $535,000. Finally, Rothschild Wealth LLC purchased a new stake in shares of Viemed Healthcare in the fourth quarter valued at about $967,000. Institutional investors and hedge funds own 74.24% of the company’s stock.

Viemed Healthcare Stock Performance

Shares of VMD stock opened at $10.53 on Thursday. The firm has a 50-day moving average of $9.70 and a 200-day moving average of $8.64. The company has a market cap of $403.72 million, a P/E ratio of 28.46 and a beta of 1.12. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.22 and a quick ratio of 1.10. Viemed Healthcare, Inc. has a one year low of $5.93 and a one year high of $10.68.

Viemed Healthcare (NASDAQ:VMD) last announced its earnings results on Tuesday, May 5th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.03). The firm had revenue of $75.41 million during the quarter, compared to analysts’ expectations of $74.40 million. Viemed Healthcare had a net margin of 5.20% and a return on equity of 10.52%. Equities research analysts forecast that Viemed Healthcare, Inc. will post 0.44 EPS for the current fiscal year.

Insider Activity at Viemed Healthcare

In other news, President Michael Moore sold 65,000 shares of the stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $8.77, for a total value of $570,050.00. Following the completion of the sale, the president owned 1,585,812 shares in the company, valued at $13,907,571.24. This represents a 3.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 20.00% of the stock is currently owned by corporate insiders.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.